This brand turned GLP-1 into a Listerine Strip.
- Vanesa Lalo
- 2 hours ago
- 2 min read
In this episode of The DTC Insider, Brian Roisentul sits down with Lekha Vyas, founder of SynQ Wellness, to break down one of the biggest trends in health right now: GLP-1 and what’s coming next.
As GLP-1 drugs like Ozempic continue to rise, most people are focused on fast weight loss.
But that’s not the full picture.
Lekha shares how long-term side effects, dependency, and lack of consumer education are creating a massive opportunity for alternatives.
She explains how her brand is building a plant-based version of GLP-1, delivered through a dissolvable strip that bypasses the gut and works directly in the bloodstream.
They also dive into what it actually takes to build a breakthrough product from 75+ iterations and human testing to finding product-market fit in a highly regulated space.
On the DTC side, they explore go-to-market strategy, why TikTok is a key channel, and how founders should think about launching and scaling in today’s landscape.
Here’s a glimpse of what you’ll learn:
• What GLP-1 is and why it’s trending right now.
• Why GLP-1 drugs can create long-term dependency.
• The hidden side effects most consumers don’t understand.
• How a plant-based alternative to GLP-1 works.
• Why sublingual delivery changes absorption and effectiveness.
• How blood sugar regulation impacts weight loss and cravings.
• What it takes to build a breakthrough wellness product.
• How to validate a product with real human testing.
• Go-to-market strategies for launching a new DTC brand.
• Why TikTok is a key growth channel today.
Resources mentioned in this episode:
Sponsor for this episode:
This episode is brought to you by BSR.
BSR helps 7-figure+ brands build and optimize strategic growth systems that unlock hidden revenue and scale profitably, without adding chaos, channels, or unnecessary spend.
To learn more about BSR, visit their website or book a call here.
Comments